Mesentech Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Investors
-
19
Mesentech General Information
Description
Developer of prostaglandin prodrugs designed to support musculoskeletal regeneration. The company's drug conjugates target mesenchymal stem cells with a potent sub-nano-molar prostaglandin mimetic that is released selectively in the bone, resulting in bone regeneration, enabling hospitals to treat low-bone-density disorders and hopes to rescue non-unions from surgical revision and accelerate bone healing.
Contact Information
Website
www.mesentech.comCorporate Office
- 2222 Health Sciences Mall
- Vancouver, British Columbia V6T 1Z3
- Canada
Corporate Office
- 2222 Health Sciences Mall
- Vancouver, British Columbia V6T 1Z3
- Canada
Mesentech Timeline
Mesentech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 01-Nov-2024 | Completed | Clinical Trials - Phase 1 | |||
| 9. Later Stage VC | 04-Oct-2023 | Completed | Clinical Trials - Phase 1 | |||
| 8. Early Stage VC | 13-Apr-2022 | Completed | Clinical Trials - Phase 1 | |||
| 7. Accelerator/Incubator | 04-Dec-2020 | Completed | Clinical Trials - Phase 1 | |||
| 6. Early Stage VC | 02-Nov-2020 | Completed | Clinical Trials - Phase 1 | |||
| 5. Early Stage VC | 24-May-2019 | Completed | Clinical Trials - Phase 1 | |||
| 4. Accelerator/Incubator | 07-May-2019 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 01-Dec-2018 | Completed | Clinical Trials - Phase 1 | |||
| 2. Accelerator/Incubator | 01-Dec-2018 | Completed | Clinical Trials - Phase 1 | |||
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Mesentech Comparisons
Industry
Financing
Details
Mesentech Competitors (4)
One of Mesentech’s 4 competitors is IRulya Therapeutics, a Formerly VC-backed company based in New Haven, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IRulya Therapeutics | Formerly VC-backed | New Haven, CT | ||||
| Angitia Biopharmaceuticals | Venture Capital-Backed | Westlake Village, CA | ||||
| Amgen | Formerly PE-Backed | Thousand Oaks, CA | ||||
| Ultragenyx Pharmaceutical | Formerly VC-backed | Novato, CA |
Mesentech Patents
Mesentech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026013441-A1 | Bisphosphonate-ep4 agonists for selective delivery to damaged muscle | Pending | 10-Jul-2024 |
Mesentech Signals
Mesentech Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 7G Bioventures | Venture Capital | Minority | ||
| Boutique Venture Partners | Venture Capital | Minority | ||
| Charles H. Hood Foundation | Limited Partner | Minority | ||
| CureDuchenne Ventures | Corporate Venture Capital | Minority | ||
| Morningside Group | Venture Capital | Minority |
Mesentech FAQs
-
When was Mesentech founded?
Mesentech was founded in 2018.
-
Where is Mesentech headquartered?
Mesentech is headquartered in Vancouver, Canada.
-
What is the size of Mesentech?
Mesentech has 11 total employees.
-
What industry is Mesentech in?
Mesentech’s primary industry is Drug Discovery.
-
Is Mesentech a private or public company?
Mesentech is a Private company.
-
What is Mesentech’s current revenue?
The current revenue for Mesentech is .
-
How much funding has Mesentech raised over time?
Mesentech has raised $27.5M.
-
Who are Mesentech’s investors?
7G Bioventures, Boutique Venture Partners, Charles H. Hood Foundation, CureDuchenne Ventures, and Morningside Group are 5 of 19 investors who have invested in Mesentech.
-
Who are Mesentech’s competitors?
IRulya Therapeutics, Angitia Biopharmaceuticals, Amgen, and Ultragenyx Pharmaceutical are competitors of Mesentech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process